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a b s t r a c t
Objective: To compare the efficacy of a new dentifrice containing 1.5% arginine, an insoluble
calcium compound, and 1450 ppmfluoride to amatched, positive control dentifrice contain-
ing 1450 ppm fluoride in arresting and reversing early coronal caries lesions in children
using Quantitative Light-induced Fluorescence (QLF).
Study design: 331 children from Chiang Mai, Thailand, aged 7–14 years, with one or more
visible early enamel caries lesions on the upper anterior teeth, completed the study. The
new dentifrice contained 1.5% arginine, an insoluble calcium compound, and 1450 ppm
fluoride, as sodium monofluorophosphate; the matched positive control contained
1450 ppm fluoride only. Subjects brushed twice daily at home and additionally once on
school days under teacher’s supervision. Digital images of the upper six anterior teeth were
captured at the baseline, 3- and 6-month examinations using a custom apparatus for
reproducible acquisition of Quantitative Light-induced Fluorescence data.
Results: At the 3-month examination, the DQ (representing lesion volume) for the test group
decreased from amean of 28.62 at baseline to 20.53 mm2% and for the positive control group
to 23.38 mm2%. The difference between groups was not statistically significant (p = 0.055).
At the 6-month examination, the DQ decreased for the test group to 15.85 mm2% and for the
positive control group to 20.35 mm2%. The difference between groups was statistically
significant ( p < 0.001).
Conclusion: A new dentifrice containing 1.5% arginine, an insoluble calcium compound, and
s sodium monofluorophosphate, provided statistically significant
rresting and reversing active coronal caries lesions in children than
hed positive control dentifrice containing fluoride alone.superior efficacy in a
brushing with a matc1450 ppm fluoride, a# 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.* Corresponding author. Tel.: +44 0161 232 4705; fax: +44 0161 232 4700.
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During the last two decades, the management of dental
caries has improved significantly as our understanding of
both the methods available to identify lesions and the
therapeutic approaches to arrest or reverse them have
become more clearly understood. The most successful
therapeutic interventions are based on the arrest or re-
mineralization of initial enamel or root caries lesions that
are not cavitated.1 Such lesions are amenable to plaque
control measures that remove the biofilm and reduce acid
production by cariogenic bacteria. They are also readily
amenable to treatment with various forms of fluoride to
facilitate re-mineralization and inhibit de-mineralization
with the formation of fluorapatite.2 Fluoride dentifrice
augments the effects of plaque removal attained through
brushing by delivering fluoride throughout themouth for the
treatment and prevention of carious lesions. Fluoride
dentifrice is one of the few therapeutic interventions
currently available in dentistry with a strong evidence base
for efficacy in caries prevention.3
Recently, an alternative approach to the management
of dental caries has been identified and validated. The basis
of the approach, which combines arginine and an insoluble
calcium compound, is to complement and enhance
the effects of fluoride by specifically targeting dental plaque,
modulating its metabolism to reduce the production
and effects of bacterial acid and, thereby, to reduce its
pathogenicity.4,5 The arginine component is metabolized to
ammonia by non-pathogenic arginolytic organisms, such as
S. sanguis, that possess an arginine deiminase pathway.
This ammonia, in turn, neutralizes plaque acids and
stabilizes the residual plaque biofilm on susceptible tooth
surfaces. By this means, arginine can prevent a shift in oral
flora to aciduric bacterial species, such as S. mutans, and
can help to maintain a non-cariogenic plaque after sugar
challenge.4–6 The result is that plaque pH is more basic,
encouraging re-mineralization; while, at the same time,
less acid is produced reducing de-mineralization.7 Further,
the insoluble calcium compound is available as a source of
free calcium ions to supplement the re-mineralization
process.4–6,8
The anti-caries benefits of this approach have been
demonstrated in two studies which compared the ability of
a new dentifrice containing 1.5% arginine, an insoluble
calcium compound, and 1450 ppm fluoride, as sodium
monofluorophosphate (MFP), to re-mineralize non-cavitated
primary root caries lesions. In one study, use of the new
dentifrice was compared to that of both a positive and
negative control dentifrice. After 6 months use of the
arginine-containing dentifrice, only one lesion (0.7%) had
become worse and 61.7% of subjects improved with lesions
becoming hard. In contrast, for the positive control dentifrice
containing 1450 ppm fluoride, as sodium fluoride, in a silica
base, 9.0% of subjects becameworse and 56.0% improved. For
the fluoride-free, matched negative control, 18.2% became
worse and only 27% improved. The differences between the
new arginine-containing dentifrice and both the positive and
negative control dentifrices were statistically significant( p < 0.001).9 In the other study use of the new dentifrice
was compared to a matched positive control. After 6 months
use, 70.5% of subjects in the arginine-containing dentifrice
group and 58.1% of subjects in the matched positive control
improved; the difference was statistically significant
( p < 0.05).10
The anti-caries benefits of this approach on the arrest and
reversal of buccal enamel carious lesions have also been
investigated in three 6-month studies using Quantitative
Light-induced Fluorescence (QLF) methods to measure
changes in mineralization of enamel lesions. One of these
studies is reported in this paper. In the other two studies, the
new dentifrice containing 1.5% arginine, an insoluble calcium
compound, and 1450 ppm fluoride, as MFP, was compared to a
matched dentifrice with neither fluoride nor arginine as a
negative control, and to a 1450 ppm fluoride only dentifrice as
a positive control. In the first study, after 6 months use of the
product, the mean lesion size reduced by 50.7% for the
arginine-containing dentifrice, 32.3% for the positive control,
and 11.4% for the negative control. The differences between
the arginine-containing dentifrice and both the positive and
negative control dentifrices were statistically significant
( p < 0.005).11 In the second study, after 6 months product
use, the mean lesion size was reduced by 50.6% for the
arginine-containing dentifrice, 34.0% for the positive control
and 13.1% for the negative control. Again, the differences
between the arginine-containing dentifrice and both the
positive and negative control dentifrices were statistically
significant (p < 0.01).12
The Quantitative Light-induced Fluorescence (QLF)method
is based upon the principle that when a tooth is stimulated
with blue light it fluoresces green. When dental caries is
present, the emitted green light is scattered within the lesion
and, hence, this area of the tooth surface appears to be dark
against a green background. By comparing the loss of
fluorescence, due to scattering in the lesion, to the background
level of fluorescence, both the area and degree of de-
mineralization (DF) of the lesion can be quantified. Further,
the product of the lesion area and the loss of fluorescence (DF)
can be used to estimate the volume of the lesion, known asDQ.
This method has been employed in a number of clinical
studies and has been shown to be both valid and highly
reliable in quantifying the progression and reversal of early
coronal caries lesions.13–16
Finally, a 2-year conventional caries clinical study has
proven that two dentifrices containing 1.5% arginine and
1450 ppm fluoride in a calcium base, one with di-calcium
phosphate and the other with calcium carbonate, are
significantly more effective in preventing the formation of
cavitated caries lesions than a dentifrice containing
1450 ppm fluoride alone. Three trained and calibrated
dentists examined the children at baseline and after one
and two years using the National Institute of Dental Research
Diagnostic Procedures and Criteria. The number of decayed,
missing, and filled teeth (DMFT) and surfaces (DMFS) for the
three study groups were very similar at baseline, with no
statistically significant differences among groups. After one
year, there were no statistically significant differences in
caries increments among the three groups. After two years,
the twogroupsusing thedentifrices containing 1.5%arginine,
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Fig. 1 – Geometry stabilizing equipment and imaging
equipment.
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statistically significantly ( p > 0.02) lower DMFT increments
(21.0% and 17.7% reductions, respectively) and DMFS incre-
ments (16.5% and 16.5%) compared to the control dentifrice.
The differences between the two groups using the new
dentifrices were not statistically significant. The results of
this pivotal clinical study support the conclusion that
dentifrices containing 1.5% arginine, an insoluble calcium
compound, and 1450 ppm fluoride provide superior protec-
tion against caries lesion cavitation to dentifrices containing
1450 ppm fluoride alone.17
The aim of the current study was to confirm the
hypothesis that the new dentifrice containing 1.5% arginine,
an insoluble calcium compound and 1450 ppm fluoride, as
sodium monofluorophosphate (MFP), is more effective in
arresting and reversing naturally occurring buccal caries
lesions in children than a regular dentifrice containing
fluoride alone using QLF.2. Methods
This study was a randomized, double-blind controlled clinical
trial of 6monthsduration inwhich anewdentifrice containing
1.5% arginine, an insoluble calcium compound, and 1450 ppm
fluoride, as MFP, was compared to an identical fluoride
dentifrice without the inclusion of arginine as a positive
control. The study received ethical approval from the Ethics
Committee of the Faculty of Dentistry, Chiang Mai University,
Chiang Mai, Thailand.
The subjects who consented to take part in the study were
7–14 years old school children with one or more visible early
enamel buccal caries lesions (white spot caries) on the upper
anterior permanent teeth. They were recruited from eight
schools in Chiang Mai, Thailand that were selected on the
basis that they were able to take part in a daily supervised
tooth brushing program. The fluoride level in the drinking
water of the communities included in the study was
<0.03 ppm F.
For consenting subjects, a screening examination was
conducted to see if they were suitable to be included in the
study. Participants in the study had to be 7–14 years old,
available for the duration of the study, and have visual
evidence of early enamel buccal caries in one or more of the
upper anterior permanent teeth.
Students meeting the inclusion criteria were centrally,
randomly allocated to study group by the study administrator
using a randomly generated series of numbers. They were
instructed to use their dentifrice twice daily at home. On
school days, they also brushed their teeth in school after lunch
under the supervision of school teachers. On approximately
half the brushing days, tooth brushing was monitored by
study personnel and compliance logged. During the 6 months
of the study, the children brushed on approximately 105 days
in school.
At each brushing, subjects were instructed to cover the
head of the toothbrush with paste. Colgate Extraclean
Professional 35 toothbrushes (Colgate-Palmolive, New York,
NY, USA) were provided for use at home and in school. All
dentifrices were supplied in identical white laminated tubesand the products were identical in terms of taste and
consistency. Toothbrushes and dentifrice were distributed to
each subject on the day of the baseline examination and
again at the 3-month examination. Intermediate supplies of
dentifrice were supplied by the school teacher when
required.
At the screening examination and all subsequent
examinations (baseline, 3 and 6 months), an examination
of the soft and hard tissues of the mouth was conducted.
Subjects then had digital images taken of the upper six
anterior teeth using a custom apparatus. Prior to imaging,
plaque was removed from the upper anterior teeth, first by
the student brushing and second by a dentist manually, to
ensure that lesions could be clearly identified and measured.
The equipment was designed to enable the capture of
Quantitative Light-induced Fluorescence images in a repro-
ducible manner. The geometry stabilizing equipment is
illustrated in Fig. 1. The imaging equipment consisted of a 3
CCD camera (Jai M91P, Jai Corporation, Copenhagen,
Denmark), a 16-mm f1.4 lens (Pentax, Slough, UK), and a
long pass yellow filter (495 nm, Schott, Stafford, UK). The
light source was a custom-made blue LED array with band
pass filter at 370 nm.
Images were acquired using QLF Patient software (Version
3.03 Inspektor Research Systems BV, Amsterdam, The
Netherlands). At the 3- and 6-month visits, the integral video
repositioning software was employed with a grab level of 0.95
to accurately reposition students relative to the baseline
image. Images were analyzed to calculate lesion area and loss
of fluorescence (DF) using QLF 2.00 (Inspektor Research
Systems BV). All images were taken by the same examiner.
For 34 subjects, duplicate baseline images were captured
without the video repositioning function to assess the
reproducibility of the method. For DQ, the Intra Class
Correlation Coefficients (ICC) at the baseline, 3- and 6-month
examinations were, respectively, 0.95, 0.95 and 0.94 between
the original and duplicate image sets.
2.1. Statistical analysis
The QLF software was used to calculate the area (mm2) and
loss of fluorescence (DF) of the lesion using a threshold of
difference of 5% from the reconstructed image. Then DF and
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the lesion.18,19
The primary outcome for this study was the mean subject
DQ at the 6-month examination. The two study groups were
compared using a Linear Model controlling for baseline DQ,
and number of lesions per subject, with a level of statistical
significance set at p < 0.05.3. Results
3.1. Disposition of subjects
Consent forms were sent out to a total of 445 children
and 437 of them consented to take part in the study. The
other eight children had left the school between the consent
form being sent out and the study commencing. Of the
consenting students, 341 children satisfied the inclusion
criteria and were recruited into the study. Between the
baseline and 3-month examination, six students were lost
from the study as they had moved to other schools. Between
the 3- and 6-month examinations, a further four children
were lost from the study for the same reason. A total of 331
students completed the study of which 166 used the test
dentifrice containing 1.5% arginine, and 165 used the
positive control dentifrice with fluoride alone (Fig. 2). Of
children completing the study, 55% were male and the mean
age of the subjects was 11.3 (1.2) years at the baseline
examination[(Fig._2)TD$FIG]
Fig. 2 – Disposition of childre3.2. Clinical results
It can be seen in Table 1 that subjects had amean of 3.8 lesions
included in the study with a range of 1–6. The baseline mean
DF, area and DQ were 8.62%, 2.56 mm2 and 28.62 mm2%. For
both groups, the mean values for all parameters were not
statistically significant different indicating good baseline
balance.
At the 3-month examination (Table 2), all three QLFmetrics
improved in both groups, with decreases in both lesion size
and loss of fluorescence. For the arginine-containing denti-
frice group, the DQ decreased from a mean of 28.62–
20.53 mm2% representing a 28% improvement. For the fluoride
only positive control group, the adjusted mean decreased to
23.38 mm2%, an improvement of 18% compared to the
baseline mean. The difference in improvement between the
test and control groups just failed to attain statistical
significance (p = 0.055).
At the 6-month examination, further improvements in
lesions were observed for all QLF metrics for both groups. For
the arginine-containing dentifrice group, the baseline adjust-
ed DQ decreased from a mean of 28.62 at baseline to
15.85 mm2% representing a 44.6% improvement. For the
fluoride only positive control group, the adjusted mean
decreased to 20.35 mm2%, an improvement of 28.9% compared
to the baseline mean. The difference between the two groups
was statistically significant (p < 0.001). The difference in
lesion area between the two groups also attained statistical
significance (p = 0.003).n throughout the study.
Table 1 – Subject mean (SD) QLF metrics (DF, area and DQ) at baseline and 3 and 6 months for the three study groups and
number of lesions at baseline.
Groups N lesions/
subject
Baseline 3 Months 6 Months
DF
(%)
Area
(mm2)
DQ
(mm2%)
DF
(%)
Area
(mm2)
DQ
(mm2%)
DF
(%)
Area
(mm2)
DQ
(mm2%)
1.5% arginine/
1450 MFP
3.81
(1.14)
8.56
(2.25)
2.53
(2.92)
28.89
(42.50)
7.94
(2.01)
1.94
(2.34)
20.72
(30.45)
7.65
(1.79)
1.59
(1.90)
16.00
(23.70)
1450 MFP 3.85
(1.21)
8.68
(2.31)
2.59
(2.17)
28.35
(30.38)
8.09
(2.22)
2.12
(2.09)
23.20
(30.05)
7.97
(2.09)
1.94
(1.78)
20.20
(24.82)
Table 2 – Baseline adjusted subject mean (SE) QLF metrics (DF, area and DQ) at 3 and 6 months for the three study groups
with number of lesions at baseline as covariable.
Groups Adjusted 3 months Adjusted 6 months
DF (%) Area (mm2) DQ (mm2%) DF (%) Area (mm2) DQ (mm2%)
1.5% Arginine/1450 MFP 7.98 (0.10) 1.96 (0.08) 20.53 (1.05) 7.68 (0.10) 1.61 (0.07) 15.85 (1.00)
1450 MFP 8.05 (0.10) 2.10 (0.08) 23.38 (1.05) 7.93 (0.10) 1.92 (0.07) 20.35 (1.00)
Baseline mean employed
in linear regression
8.62 2.56 28.62 8.62 2.56 28.62
Statistical significance of
difference between groups
0.66 0.24 0.055 0.095 0.003 0.001
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This study has, once again, demonstrated that the new
dentifrice containing 1.5% arginine, an insoluble calcium
compound, and 1450 ppm fluoride, as MFP, significantly
improves the anti-caries efficacy as compared to conventional
1450 ppm fluoride dentifrice. After 6 months use of the
arginine-containing product, lesions had reduced in mean
size from baseline by 44.6% compared to only 28.9% reduction
for the conventional 1450 ppm fluoride dentifrice. In fact, the
reduction in lesion size of 28%achieved after just 3months use
of the arginine-containing dentifrice was very similar to that
achieved after 6 months use of the conventional fluoride
dentifrice indicating that lesions were re-mineralizing twice
as quickly with the arginine-containing dentifrice as with the
fluoride dentifrice. Thus, this study confirmed the hypothesis
that the new dentifrice containing 1.5% arginine, an insoluble
calcium compound, and 1450 ppm fluoride is more effective
than a matched positive control dentifrice containing
1450 ppmfluoride alone in arresting and reversing early caries
lesions in children.
In two studies, using the same methods, very similar
results were observed, with reductions in lesion area of
approximately 50% in the group using the dentifrice contain-
ing 1.5% arginine, and insoluble calcium compound and
1450 ppm fluoride, as MFP, and of approximately 33% in the
groups using the 1450 ppm fluoride positive control denti-
frices.11,12 In the two previous studies, fluoride-free matched
negative control dentifrices were also included to assess the
effect of brushing with dentifrice without fluoride. An
approximately 12% reduction in lesion size was attributable
to brushing alone at the 6-month examination in these two
studies.11,12 Thus, this study and the two further studies
confirmed the hypothesis that the new dentifrice containing
1.5% arginine, an insoluble calcium compound, and 1450 ppmfluoride is more effective than a positive control dentifrice
containing 1450 ppm fluoride alone in arresting and reversing
early caries lesions in children.
Based upon an in vivo plaquemetabolism study, 7 aswell as
in situ remineralization and demineralization studies,8 the
mechanism of action of this new dentifrice in providing
superior remineralization of early caries lesions to dentifrices
containing 1450 ppmfluoride alone is comprised of two critical
elements: (1)metabolic breakdownof the delivered arginine to
ammonia in plaque,which helps neutralize acids formed from
dietary sugars, resulting in higher resting and terminal plaque
pH values and a higher degree of super-saturation by calcium
and phosphate to drive the remineralization process, and (2)
delivery of an insoluble calcium compound which acts as a
reservoir of free calcium to aid remineralization.4,5
Traditional clinical studies are routinely conducted on
large numbers of subjects (4000) and last 2–3 years in order
that cavities develop sufficiently to be detected using
conventional visual or visual/tactile criteria. The ethics of
conducting such studies when the most likely resulting
intervention will be restoration, is now being questioned. It
is known that therapeutic treatment of initial carious lesions
is both possible and practical, and by employing sophisticated
detection and measurement methods, outcomes can be
monitored so that participants receive optimum, minimally
invasive treatment.
In particular, the QLF method has proven to be a powerful
tool in the caries clinical hierarchy providing unique insights
regarding efficacy and mechanism of action of anti-caries
products on early coronal caries lesions that complement and
augment those generated in traditional 2-year caries studies of
cavitation.
This study confirms that the use of Quantitative Light-
induced Fluorescence (QLF) in studies of early coronal caries
significantly improves the ability to discriminate between
anti-caries products, enabling the studies to be conducted
j o u rn a l o f d e n t i s t r y 4 1 s ( 2 0 1 3 ) s 2 9 – s 3 4S34effectively in shorter time periods with fewer participants. In
addition, the ability of products to re-mineralize initial carious
lesions is measured accurately and at the stage prior to
cavitation,when suchproducts are likely to bemost beneficial.5. Conclusion
It is concluded from this, and other studies, that a new
dentifrice containing 1.5% arginine, an insoluble calcium
compound and 1450 ppm fluoride, as MFP, significantly
improves the re-mineralization of carious lesions as compared
to dentifrice containing 1450 ppm fluoride alone.Conflict of interest statement
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